GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinuvel Pharmaceuticals Ltd (OTCPK:CLVLY) » Definitions » Inventory Turnover

CLVLY (Clinuvel Pharmaceuticals) Inventory Turnover : 0.77 (As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Clinuvel Pharmaceuticals Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Clinuvel Pharmaceuticals's Cost of Goods Sold for the six months ended in Jun. 2024 was $5.98 Mil. Clinuvel Pharmaceuticals's Average Total Inventories for the quarter that ended in Jun. 2024 was $7.73 Mil. Clinuvel Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2024 was 0.77.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Clinuvel Pharmaceuticals's Days Inventory for the six months ended in Jun. 2024 was 235.87.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Clinuvel Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.21.


Clinuvel Pharmaceuticals Inventory Turnover Historical Data

The historical data trend for Clinuvel Pharmaceuticals's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinuvel Pharmaceuticals Inventory Turnover Chart

Clinuvel Pharmaceuticals Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.60 2.17 3.96 1.54 1.00

Clinuvel Pharmaceuticals Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.54 0.61 0.98 0.10 0.77

Clinuvel Pharmaceuticals Inventory Turnover Calculation

Clinuvel Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Jun. 2024 is calculated as

Inventory Turnover (A: Jun. 2024 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Jun. 2024 ) / ((Total Inventories (A: Jun. 2023 ) + Total Inventories (A: Jun. 2024 )) / count )
=6.694 / ((6.389 + 7.056) / 2 )
=6.694 / 6.7225
=1.00

Clinuvel Pharmaceuticals's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover (Q: Jun. 2024 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Jun. 2024 ) / ((Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Jun. 2024 )) / count )
=5.982 / ((8.407 + 7.056) / 2 )
=5.982 / 7.7315
=0.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinuvel Pharmaceuticals  (OTCPK:CLVLY) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Clinuvel Pharmaceuticals's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory =Average Total Inventories (Q: Jun. 2024 )/Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=7.7315/5.982*365 / 2
=235.87

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Clinuvel Pharmaceuticals's Inventory to Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Jun. 2024 ) / Revenue (Q: Jun. 2024 )
=7.7315 / 37.132
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Clinuvel Pharmaceuticals Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Clinuvel Pharmaceuticals's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Clinuvel Pharmaceuticals Business Description

Address
535 Bourke Street, Level 22, Melbourne, VIC, AUS, 3000
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.

Clinuvel Pharmaceuticals Headlines

From GuruFocus

Letter to shareholders from CLINUVEL's CEO

By GuruFocusNews GuruFocusNews 04-29-2022

CLINUVEL progresses vitiligo treatment program

By GuruFocusNews GuruFocusNews 06-29-2022

First patient dosed in SCENESSE� DNA Repair Program

By Marketwired Marketwired 09-15-2020

CLINUVEL Launches CYAC�LLE, Next Generation Solar Care

By sperokesalga sperokesalga 03-01-2023

CLINUVEL to Trial Innovative Drug in Stroke

By Marketwired Marketwired 10-28-2020

PRÉNUMBRA® - CLINUVEL's Second Afamelanotide Formulation

By Marketwired Marketwired 07-13-2020

CLINUVEL Trial Results Show Drug Reduces DNA Damage

By Stock market mentor Stock market mentor 01-16-2023